August 31, 2016 9:18 PM ET

Biotechnology

Company Overview of Alkermes plc

Executive Profile

David Westbrook Anstice

Independent Director and Chairman of Compensation Committee, Alkermes plc
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 5 different industries.

See Board Relationships
68$464,642

Background

Mr. David Westbrook Anstice served as Executive Vice President of Strategy Initiatives at Merck & Co., Inc. from September 2006 to September 2008. Mr. Ansticeserved as the President of Human Health of Merck & Co., Inc. from January 2003 to September 2006 and was responsible for its prescription drug business in Japan, Latin America, Canada, Australia, New Zealand and its joint venture relationship with Schering-Plough. He spent 34 years with Merck & Co., Inc. Mr. Anstice ...

Corporate Headquarters

Connaught House
Dublin, Co. Dublin D04 C5Y6

Ireland

Phone: 353 1 772 8000
Fax: --

Board Members Memberships

Trustee
Director
2008-Present
Independent Director and Chairman of Compensation Committee
2008-Present
Independent Non-Executive Director, Member of Nomination Committee, Member of Human Resources & Remuneration Committee and Member of Innovation & Development Committee
2008-Present
Director

Education

Bachelor's Degree 1970
University Of Sydney

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$94,000
Total Calculated Compensation$464,642
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Pamela Louise Makin MA, Ph.D.(Cantab), MBA, DBEChief Executive Officer and Executive Director
BTG plc
$1.0M
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$869.6K
Said Samih Taleb Darwazah Chairman and Chief Executive Officer
Hikma Pharmaceuticals PLC
$4.1M
Leon O. Moulder Jr., M.B.A.Co-Founder, Chief Executive Officer and Director
Tesaro, Inc.
$618.1K
Shaun Thaxter Chief Executive Officer and Director
Indivior PLC
$2.1M
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Alkermes plc, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.